2026 NPPES data Medical Oncology Physician NPI 1811316714
Verify on CMS →

ADAM WIDMAN

Medical Oncology Physician in MIDDLETOWN, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
230
Medicare Part D claims · 77 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
85%
generic claims · 15% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
89.6113/100
▲ 7 pts above national avg 83.1 · [object Object]

What the federal data shows

ADAM WIDMAN reported a CMS MIPS final score of 89.6113/100 — above the 83.1 national average — and filed 230 Medicare Part D claims in 2023.

89.6113/100
MIPS score · +7 vs avg
230
Part D claims, 2023
85%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ADAM WIDMAN's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

90 Top 42% higher than 58% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

ADAM WIDMAN practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ADAM WIDMAN?

High performer (top quartile)

NPI registry status

Active

Issued 04/08/2014

NPI 1811316714

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

230 67% vs specialty avg

2023 prescription claims

Specialty avg: 689

MIPS final score

89.6113/100 6.511300000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New Jersey

How Medical Oncology Physician compares to other specialties among New Jersey providers

New Jersey providers

Medical Oncology Physician share within New Jersey

1. Medical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Medical Oncology Physician share within New Jersey

Medicare quality performance — MIPS

ADAM WIDMAN's 2023 MIPS final score plotted against the Medical Oncology Physician national average

High performer (top quartile)
MIPS Final Score
89.6113/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Medical Oncology Physician) — 89.6113/100 vs national avg 83.1

0%100%National avg83%89.6%
MIPS final score (Medical Oncology Physician) — 89.6113/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ADAM WIDMAN appears in the CMS NPPES registry as a Medical Oncology Physician provider at 480 RED HILL RD, MIDDLETOWN, NJ, 07748, with a listed phone of (848) 225-6111. NPI 1811316714 was issued on 04/08/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WIDMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 230 prescription claims written by this provider, covering 77 Medicare beneficiaries and totaling roughly $494K in drug spend, split 15% brand-name and 85% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 89.6113/100 for the 2023 performance year (Quality 81.8956), compared with the national average of 83.1.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

480 RED HILL RD
MIDDLETOWN, NJ 07748

Provider Details

NPI 1811316714
Specialty Medical Oncology Physician
Gender Male
NPI Issued 04/08/2014

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

89.6113
Final Score
Avg: 83.1
81.8956
Quality

Reporting: Group practice

Hospital and facility affiliations

Facilities where ADAM WIDMAN bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

MEMORIAL SOLID TUMOR GROUP
NEW YORK, NY
MSK MONMOUTH
MIDDLETOWN, NJ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Typical

ADAM WIDMAN — brand share 15.0%
Specialty average (est.)

15% brand-name claims vs 85% generic, on 230 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

230
Total Claims
$494K
Total Drug Cost
77
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
462
Total Day Supply
13,394
Brand vs Generic
15% brand / 85% generic
Brand Drug Cost
$489K
Generic Drug Cost
$5K

Patient Demographics

Average Patient Age
74.0 years
Avg HCC Risk Score
1.31

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ADAM WIDMAN prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Letrozole
85
Verzenio
Abemaciclib
21
Ondansetron Hcl
13
Anastrozole
12
Ibrance
Palbociclib
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How ADAM WIDMAN fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

ADAM WIDMAN's 230 claims are below the specialty average of 689.

Nearby Medical Oncology Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as WIDMAN.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ADAM WIDMAN's specialty?
ADAM WIDMAN specializes in Medical Oncology Physician and practices in MIDDLETOWN, New Jersey.
How much does ADAM WIDMAN prescribe under Medicare Part D?
In 2023, ADAM WIDMAN wrote 230 Medicare Part D claims totaling $494K in drug costs for 77 beneficiaries.
What is ADAM WIDMAN's Medicare quality score?
ADAM WIDMAN has a CMS MIPS Final Score of 89.6113/100 (Quality: 81.8956). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ADAM WIDMAN located?
ADAM WIDMAN is located at 480 RED HILL RD, MIDDLETOWN, NJ, 07748. Phone: (848) 225-6111.
What is ADAM WIDMAN's NPI number?
ADAM WIDMAN's National Provider Identifier (NPI) is 1811316714, issued on 04/08/2014.
Does ADAM WIDMAN prescribe more brand-name or generic drugs?
ADAM WIDMAN's prescribing is 15% brand-name and 85% generic drugs by claim count, with $489K in brand drug costs.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does ADAM WIDMAN prescribe most often?
Based on 2023 Medicare Part D data, ADAM WIDMAN's most frequently prescribed drugs include Letrozole, Verzenio, Ondansetron Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ADAM WIDMAN accept Medicare?
ADAM WIDMAN appears in CMS Medicare data with 230 Part D claims and 77 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ADAM WIDMAN's credentials?
ADAM WIDMAN's NPI is 1811316714. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology